ESR1 and breast carcinoma: Upregulated mSigDB modules include pathways typically associated with breast cancer invasiveness, including SMARCE1 targets (p-value 2.6E−16), ESR1 targets (p-value 5.3E−16), and a comparison of luminal and mesenchymal breast cancers (p-value 2.1E−12).